Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites

Background: In epithelial ovarian cancer (EOC), 15–20% of the tumors do not respond to first-line chemotherapy (paclitaxel with platinum-based therapy), and in recurrences this number increases. Our aim is to determine the feasibility of cell proliferation assays of tumor cells isolated from maligna...

Descripción completa

Detalles Bibliográficos
Autores principales: den Ouden, Judith E., Zaman, Guido J.R., Dylus, Jelle, van Doornmalen, Antoon M., Mulder, Winfried R., Grobben, Yvonne, van Riel, Wilhelmina E., de Hullu, Joanne A., Buijsman, Rogier C., van Altena, Anne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733621/
https://www.ncbi.nlm.nih.gov/pubmed/33346216
http://dx.doi.org/10.18632/oncotarget.27827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733621/
https://www.ncbi.nlm.nih.gov/pubmed/33346216
http://dx.doi.org/10.18632/oncotarget.27827

Ejemplares similares